Andrea Pretta, Medical Oncologist and Clinical Researcher at University Hospital of Cagliari, shared on LinkedIn:
“It was a pleasure and an honor to participate as an invited speaker at the 28th National Congress of the Italian Association of Medical Oncology (AIOM) in Rome.
My presentation, ‘Continuum of Care in Later Lines of Treatment’, focused on treatment strategies beyond first-line therapy in metastatic colorectal cancer, with particular emphasis on molecular selection, emerging evidence, and the personalization of treatment sequencing.
As therapeutic options continue to expand, the challenge is not only to select the most appropriate treatment, but also to develop a comprehensive strategy that maximizes opportunities throughout the entire patient journey.
Many thanks to AIOM for the invitation and this valuable opportunity for scientific exchange.”
You can also read: Beyond MSI Status: A New Biomarker of Immunotherapy Resistance in Colorectal Cancer
